aTyr Pharma, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire aTyr Pharma, Inc.
Quantité totale PI 161
Rang # Quantité totale PI 8 163
Note d'activité PI 2,4/5.0    28
Rang # Activité PI 27 738
Symbole boursier
ISIN US0021202025
Capitalisation 131M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

89 1
28 1
41 1
0
 
Dernier brevet 2025 - Compositions and methods compris...
Premier brevet 2003 - Method for stimulating wound hea...
Dernière marque 2013 - ATYR PHARMA
Première marque 2007 - ATYR PHARMA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies and antigen-bi...
2023 Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are affinity matured and huma...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies, and antigen-b...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies, and antigen-bi...
Invention Compositions and methods comprising anti-nrp2b antibodies. Provided are antibodies and antigen-b...
Invention Compositions and methods comprising anti-nrp2b antibodies. Provided are antibodies and antigen-bi...
2022 Invention Compositions and methods comprising anti-nrp2a antibodies. Provided are antibodies and antigen-b...
Invention Compositions and methods comprising anti-nrp2a antibodies. Provided are antibodies and antigen-bi...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies and antigen-bin...
Invention Compositions and methods for treating nrp2-associated diseases. Provided are therapies, includin...
2021 Invention Histidyl-trna synthetase-fc conjugates. The present invention provides histidyl-tRNA synthetase ...
2020 Invention Therapeutic compositions comprising anti-nrp2 antibodies. Provided are affinity matured and human...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are affinity matured and human...
Invention Histidyl-trna synthetase-fc conjugates. The present invention provides histidyl-tRNA synthetase a...
Invention Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical...
2019 Invention Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fra...
Invention Compositions and methods for treating nrp2-associated diseases. Provided are therapies, including...
2018 Invention Compositions and methods for treating lung inflammation. Provided are therapies, including combin...
2017 Invention Anti-hrs antibodies and combinaton therapies for treating cancers. Provided are antibodies that ...
Invention Anti-hrs antibodies and combination therapies for treating cancers. Provided are antibodies that ...
Invention Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activ...
2016 Invention Aminoacyl trna synthetases for modulating inflammation. Inflammatory and other cellular response-...
Invention Thrombopoietic activity of tyrosyl-trna synthetase polypeptides. Thrombopoietic compositions are...
2013 P/S Pharmaceutical preparations for the treatment of vascular disorders, inflammatory disorders, name...
2007 P/S Pharmaceutical preparations.
P/S pharmaceutical research and development